1. Home
  2. PRLB vs MDXG Comparison

PRLB vs MDXG Comparison

Compare PRLB & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Proto Labs Inc.

PRLB

Proto Labs Inc.

HOLD

Current Price

$53.65

Market Cap

1.1B

Sector

Industrials

ML Signal

HOLD

Logo MiMedx Group Inc

MDXG

MiMedx Group Inc

HOLD

Current Price

$5.30

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRLB
MDXG
Founded
1999
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
PRLB
MDXG
Price
$53.65
$5.30
Analyst Decision
Buy
Strong Buy
Analyst Count
3
3
Target Price
$53.00
$10.67
AVG Volume (30 Days)
124.7K
946.0K
Earning Date
02-06-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.61
0.27
Revenue
$518,384,000.00
$393,442,000.00
Revenue This Year
$7.07
$19.13
Revenue Next Year
$4.87
$2.11
P/E Ratio
$90.17
$20.07
Revenue Growth
2.82
14.77
52 Week Low
$29.59
$5.13
52 Week High
$56.60
$9.30

Technical Indicators

Market Signals
Indicator
PRLB
MDXG
Relative Strength Index (RSI) 51.19 23.04
Support Level $52.95 $5.15
Resistance Level $56.60 $5.45
Average True Range (ATR) 1.64 0.21
MACD -0.03 -0.08
Stochastic Oscillator 51.68 10.74

Price Performance

Historical Comparison
PRLB
MDXG

About PRLB Proto Labs Inc.

Proto Labs Inc is an on-demand manufacturer of custom parts for prototyping and short-run production. The company offers developers and engineers quick-turn production services to reduce the time to market. Proto Labs uses injection molding, computer numerical control machining, and 3-D printing to manufacture custom parts for its clients. The company services clients' needs for prototype solutions, parts for testing procedures, bridge production capabilities during disruptions in manufacturing processes, limited-quantity requests, and end-of-life production support. Geographically, a majority of the company's revenue is derived from the United States and the rest from Europe.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: